Japan Pharmaceutical Rapid Microbiology Testing Market Size & Outlook
The pharmaceutical rapid microbiology testing market in Japan is expected to reach a projected revenue of US$ 527.3 million by 2033. A compound annual growth rate of 12.9% is expected of Japan pharmaceutical rapid microbiology testing market from 2025 to 2033.
- Biotechnology
- Microbiology
- Pharmaceutical Rapid Microbiology Testing Market Outlook
- Microbiology
Revenue, 2024 (US$M)
$180.0
Forecast, 2033 (US$M)
$527.3
CAGR, 2025 - 2033
12.9%
Report Coverage
Japan
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the pharmaceutical rapid microbiology testing market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Japan pharmaceutical rapid microbiology testing market highlights
- The Japan pharmaceutical rapid microbiology testing market generated a revenue of USD 180.0 million in 2024 and is expected to reach USD 527.3 million by 2033.
- The Japan market is expected to grow at a CAGR of 12.9% from 2025 to 2033.
- In terms of segment, reagents & kits was the largest revenue generating product in 2024.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Pharmaceutical rapid microbiology testing market data book summary
| Market revenue in 2024 | USD 180.0 million |
| Market revenue in 2033 | USD 527.3 million |
| Growth rate | 12.9% (CAGR from 2025 to 2033) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Kits, Software, Accessories |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, BD, Danaher Corp, Sartorius AG, Abbott, QuidelOrtho Corp, Charles River Laboratories International Inc, Rapid Micro Biosystems Inc Class A |
Other key industry trends
- In terms of revenue, Japan accounted for 5.0% of the global pharmaceutical rapid microbiology testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China pharmaceutical rapid microbiology testing market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 778.7 million by 2033.
No credit card required*
Publish Date: Jan 23, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Rapid Microbiology Testing Market Scope
Pharmaceutical Rapid Microbiology Testing Market segmentation & scope
Pharmaceutical Rapid Microbiology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Sartorius AG | View profile | 14,338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | www.sartorius.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Rapid Micro Biosystems Inc Class A | View profile | 193 | 1001 Pawtucket Boulevard West, Suite 280, Lowell, MA, United States, 01854 | www.rapidmicrobio.com |
| Abbott | View profile | - | - | - |
Japan Pharmaceutical Rapid Microbiology Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Rapid Microbiology Testing Market Outlook will help companies and investors design strategic landscapes.
Reagents & Kits was the largest segment with a revenue share of 61.78% in 2024.
Horizon Databook has segmented the Japan pharmaceutical rapid microbiology testing market based on instruments, reagents & kits, software, accessories covering the revenue growth of each sub-segment from 2021 to 2033.
- Japan Pharmaceutical Rapid Microbiology Testing Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents & Kits
- Software
- Accessories
- Japan Pharmaceutical Rapid Microbiology Testing Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Growth-based Testing
- Nucleic Acid-based Testing
- Cellular Component-based Testing
- Viability-based Testing
- Other Techniques
- Japan Pharmaceutical Rapid Microbiology Testing Market Application Outlook (Revenue, USD Million , 2021-2033)
- Bioburden testing
- Sterility testing
- Endotoxin testing
- Other Applications
- Environmental monitoring
- Pyrogen testing
- Mycoplasma testing
- Microbial identification
- Japan Pharmaceutical Rapid Microbiology Testing Market Test Type Outlook (Revenue, USD Million , 2021-2033)
- Traditional/Conventional Testing
- Rapid Testing
Reasons to subscribe to Pharmaceutical Rapid Microbiology Testing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pharmaceutical Rapid Microbiology Testing Market Outlook databook
- Our clientele includes a mix of Pharmaceutical Rapid Microbiology Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Pharmaceutical Rapid Microbiology Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Pharmaceutical Rapid Microbiology Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Pharmaceutical Rapid Microbiology Testing Market, 2021-2033 (US$M)
Japan pharmaceutical rapid microbiology testing market statistics, by product, 2021-2033 (US$M)
